For more than 50 years WR Hambrecht+Co team members have provided billions of dollars in early growth capital to more than 500 companies including:
RECENT INVESTMENTS INCLUDE:
Affordable, ultra efficient, small-footprint electric vehicles that are insanely fun to drive. Makers of the FUV, Deliverator, and Rapid Responder. (NASDAQ: FUV)
AI-driven digital health assistant that helps patients self-diagnose and triage to the appropriate care.
Healthcare Electronic Data Capture, ePRO, eCOA, eConsent, IWRS, eTMF, eSource, CDMS, and decentralized clinical trial solutions on one platform.
From population genomics to high throughput COVID-19 testing, Color provides the technology & infrastructure for large scale health initiatives.
Brain-tech company addressing the challenge of understanding the human brain, paving a path for better brain health.
Low-cost telehealth appointments & prescription delivery. Meet with an online doctor or nurse practitioner from the comfort of home.
Window inserts that improve efficiency, comfort and noise levels without the need to buy new windows.
The easiest way to volunteer and manage volunteers, with mobile apps and responsive web dashboards.
Behavior change AI platform that unites behavioral science with artificial intelligence to nudge patients and employees in the right direction.
The world's largest personalized health network that helps people find new treatments, connect with others and take action to improve their outcomes.
Using AI and machine learning to decrease delayed diagnoses and empower greater personalization in women's health.
First and only FDA cleared test to confirm ovulation at home and leader in at home fertility and menstrual cycle diagnostics.
Tasso has developed the HemoLink, a virtually painless blood collection device that enables self-collection of blood samples and testing in standard lab instruments.
Provider of comprehensive health insights designed to help people track their gut microbiome health.
909 MONTGOMERY STREET, 3RD FLOOR
SAN FRANCISCO, CA 94133